Sanguine BioSciences, Inc.
4.6 out of 5 stars.
Get weekly updates, new jobs, and reviews

About Sanguine BioSciences, Inc.

Sanguine: who we are

CEO Speech at Startup Health

Sanguine Mission

Forging a Path for Early Clinical Development in Sickle Cell Disease

Sanguine Speaker Series Features Distinguished Pfizer Researchers, David Beidler and Debra Pittman.

Sanguine Mission

The Scientist Webinar Simplifying Patient Participation

Research depends on samples from patients and healthy volunteers. However, obtaining biospecimens from human subjects can be a challenge for researchers and patients alike. Home-based specimen collection directly connects patients to researchers, while alleviating the burden of travel to secondary sites. Using this approach, researchers efficiently collect patient samples in the comfort of their homes. This webinar, sponsored by Sanguine, will detail research experiences from researcher and patient perspectives. Topics to be Covered: - Development of an AI drug discovery platform for microbial-based immunotherapies using patient samples - Research from a patient's perspective - Practical considerations for engaging patients in research - The direct-to-patient trial model Featured Speakers: Christine Von Raesfeld (Independent Patient Advocate / Board member of More Than Lupus / Patient Advisor for Aurinia Pharmaceuticals / Patient Advisor for PatientsLikeMe / Participant in the Stanford Humanwide Program) Stephanie Culler, PHD (Co-Founder and CEO of Persephone Biome, Inc.)

Biobanking Today - Facebook, Crypto, Artificial Intelligence

CHI's 11th Annual Leaders in Biobanking Congress 2019 - Miami, FL Featured Speaker - CEO of Sanguine, Brian Neman

Sanguine Makes Research Participation Easier

Translational Research

We are the missing link that connects patients and researchers by providing in-home specimen collection and a mobile health platform to advance medical research

Direct to patient recruitment

Social Media



Company Details


5000 Van Nuys Boulevard #205, Sherman Oaks, CA 91403


$5M to $25M (USD)


51 to 200